TY - JOUR
T1 - Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder
AU - Hamazaki, Kei
AU - Maekawa, Motoko
AU - Toyota, Tomoko
AU - Dean, Brian
AU - Hamazaki, Tomohito
AU - Yoshikawa, Takeo
N1 - Funding Information:
This work was supported by Grant-in-Aid for Scientific Research (C) ( 25461726 ), Japan. BD is a National Health and Medical Research Council Senior Research Fellow ( APP1002240 ). This work was supported in part by the Victorian Government׳s Operational Infrastructure Support. The funding source had no role in the study design; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the paper for publication.
Funding Information:
We are grateful to Ms. Shizuko Takebe (University of Toyama) for her technical assistance and Ms. Mika Kigawa (University of Toyama) for her statistical assistance. We thank Drs. Ken-ichi Moto and Toshihide Kobayashi (RIKEN Lipid Biology Laboratory) for their technical advice. The Victorian Brain Bank Network is supported by the Florey Institute for Neuroscience and Mental Health , the Alfred Hospital , the Victorian Forensic Institute of Medicine , and the University of Melbourne , and funded by Australia׳s National Health and Medical Research Council , Helen Macpherson Smith Trust , and Parkinson׳s Victoria and Perpetual Philanthropic Services .
Funding Information:
KH has received research support from an Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry, the Japan Society for the Promotion of Science, the Tamura Foundation for Promotion of Science and Technology, and the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; consultant fees from Polyene Project, Inc. and scholarship donations from Otsuka Pharmaceutical Co., Ltd.; and has been a paid speaker for DHA & EPA Association. TH has received research support from the Japan Society for the Promotion of Science, Open Research Center for Lipid Nutrition (Kinjo Gakuin University), and Nippon Suisan Kaisha, Ltd.; consultancy fees from Polyene Project, Inc. and Otsuka Pharmaceutical Co., Ltd.; lecture fees from Otsuka Pharmaceutical Co., Ltd.; and travel expenses from Aker BioMarine.
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.
PY - 2015/6/30
Y1 - 2015/6/30
N2 - Postmortem brain studies have shown abnormal levels of n-3 polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid, in the frontal cortex (particularly the orbitofrontal cortex) of patients with depression, schizophrenia, or bipolar disorder. However, the results from regions in the frontal cortex other than the orbitofrontal cortex are inconsistent. In this study we investigated whether patients with schizophrenia, bipolar disorder, or major depressive disorder have abnormalities in PUFA levels in the prefrontal cortex [Brodmann area (BA) 8]. In postmortem studies, fatty acids in the phospholipids of the prefrontal cortex (BA8) were evaluated by thin layer chromatography and gas chromatography. Specimens were evaluated for patients with schizophrenia (. n=15), bipolar disorder (. n=15), or major depressive disorder (. n=15) and compared with unaffected controls (. n=15). In contrast to previous studies, we found no significant differences in the levels of PUFAs or other fatty acids in the prefrontal cortex (BA8) between patients and controls. Subanalysis by sex also showed no significant differences. No significant differences were found in any individual fatty acids between suicide and non-suicide cases. These psychiatric disorders might be characterized by very specific fatty acid compositions in certain areas of the brain, and BA8 might not be involved in abnormalities of PUFA metabolism.
AB - Postmortem brain studies have shown abnormal levels of n-3 polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid, in the frontal cortex (particularly the orbitofrontal cortex) of patients with depression, schizophrenia, or bipolar disorder. However, the results from regions in the frontal cortex other than the orbitofrontal cortex are inconsistent. In this study we investigated whether patients with schizophrenia, bipolar disorder, or major depressive disorder have abnormalities in PUFA levels in the prefrontal cortex [Brodmann area (BA) 8]. In postmortem studies, fatty acids in the phospholipids of the prefrontal cortex (BA8) were evaluated by thin layer chromatography and gas chromatography. Specimens were evaluated for patients with schizophrenia (. n=15), bipolar disorder (. n=15), or major depressive disorder (. n=15) and compared with unaffected controls (. n=15). In contrast to previous studies, we found no significant differences in the levels of PUFAs or other fatty acids in the prefrontal cortex (BA8) between patients and controls. Subanalysis by sex also showed no significant differences. No significant differences were found in any individual fatty acids between suicide and non-suicide cases. These psychiatric disorders might be characterized by very specific fatty acid compositions in certain areas of the brain, and BA8 might not be involved in abnormalities of PUFA metabolism.
KW - Brodmann area 8
KW - Polyunsaturated fatty acids
KW - Postmortem brain
KW - Prefrontal cortex
UR - http://www.scopus.com/inward/record.url?scp=84929128736&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929128736&partnerID=8YFLogxK
U2 - 10.1016/j.psychres.2015.01.004
DO - 10.1016/j.psychres.2015.01.004
M3 - Article
C2 - 25858798
AN - SCOPUS:84929128736
SN - 0165-1781
VL - 227
SP - 353
EP - 359
JO - Psychiatry Research
JF - Psychiatry Research
IS - 2-3
ER -